Sharing is caring . . .

Optometry News from Healio

  • VIDEO: IC-8 IOL may reduce visual disturbances in prior refractive surgery cases
    In this video perspective from the virtual Association for Research in Vision and Ophthalmology meeting, Jodhbir S. Mehta, MBBS, PhD, discusses a study on the implantation of the IC-8 IOL (AcuFocus) in patients with previous LASIK surgery. Read more »
  • FDA approves novel therapy for blepharoptosis
    Upneeq 0.1%, a novel treatment for acquired blepharoptosis, has been approved by the FDA, according to a press release.Upneeq (oxymetazoline hydrochloride ophthalmic solution, Osmotica Pharmaceuticals) is a once-daily first-in-class alpha-adrenergic agonist, which is thought to target Müller's muscle to elevate the upper eyelid.In two pivotal phase 3 efficacy studies, Upneeq demonstrated statistically significant improvements over the control in superior visual field and eyelid lift, with a separate safety study showing the drug was well-tolerated when… Read more »
  • CorneaGen commits to supporting Black community
    CorneaGen is committing $100,000 per year to ensure that members of the Black community in the United States can receive a cornea transplant regardless of their financial situation.“We make this offer to every surgeon in the U.S. regardless of geography or relationship with CorneaGen,” a community statement on the company website said. “Together we can impact this one area and ensure that race is not a limiting factor to receiving corneal care.”CorneaGen is also committing… Read more »
  • AOA elects, installs new board during virtual meeting
    The American Optometric Association announced that Kentucky’s William T. Reynolds, OD, would serve as its new president.The AOA released the results of its 2020-2021 board of trustees election, in a press release. The vote, which was originally scheduled to take place during Optometry’s Meeting 2020, was shown during a webinar broadcast on June 22.Election results also led to the installation of Robert C. Layman, OD, of Ohio as president-elect; James P. DeVleming, OD, of Washington… Read more »
  • Sildenafil shows IOP elevation properties
    Sildenafil, a phosphodiesterase type 5 inhibitor, could be used to treat ocular hypotension or postsurgical shallow anterior chamber, according to a presentation at the virtual Association for Research in Vision and Ophthalmology meeting.“In previous studies, sildenafil 50 mg and 100 mg was shown to produce a substantial increase of intraocular pressure in an animal model. The purpose of the current study was to test the same drug in human volunteers with normal IOP in the… Read more »
  • Answering the call of AAO, ophthalmologists campaign to ban rubber bullets, tear gas
    Rubber bullets and tear gas may sound innocuous and offer a false sense of security. In reality, these nonlethal weapons can cause permanent eye damage, eye injury, discomfort, pain, loss of vision and blindness.Ravi D. Goel, MD, a cataract surgeon in Cherry Hill, New Jersey, and clinical spokesman for the American Academy of Ophthalmology, actively joined the AAO #NoRubberBullets #NotOneMoreEye campaign to end the use of rubber bullets to control or disperse crowds because “while… Read more »
  • Vision Council, Reed cancel Vision Expo West
    The Vision Council and Reed Exhibitions announced the decision to cancel the Vision Expo West 2020 meeting, scheduled to take place in Las Vegas Sept. 23 to 26.The announcement follows the decision in February to consolidate the canceled Vision Expo East meeting with the Las Vegas meeting.“While certainly disappointing, the decision to cancel Vision Expo West 2020 is prudent and necessary following the announcement of the extension of phase 2 in Las Vegas into the… Read more »
  • Machine learning proves effective in measuring ellipsoid zones
    Novel machine-learning using ellipsoid zone area defect revealed a correlation of improvement in mean visual acuity and decrease in defect, according to data presented at the Association for Research in Vision and Ophthalmology annual meeting.Improvements in mean visual acuity letter score (VALS) were observed at months 1, 6 and 12, then decreased 44.4% at month 24 after no protocol-defined treatment for a year. The study comprised patients with macular edema due to central retinal or… Read more »
  • Usher syndrome linked to more vision loss than asymptomatic retinitis pigmentosa
    Usher syndrome type 2 caused greater visual field loss than asymptomatic retinitis pigmentosa, according to data presented at the Association for Research in Vision and Ophthalmology annual meeting.“Patients who had Usher syndrome had worse visual field sensitivity or ability to see off to the side than those who had retinitis pigmentosa without any hearing loss. This measurement that we made — a quantitative measurement of side vision using a particular algorithm — was a very… Read more »
  • The ‘journey’ matters: OCT fluctuations correlate with vision gains
    Patients who demonstrated larger fluctuations in central foveal thickness, or CFT, experienced numerically smaller vision gains, according to a post hoc analysis of data from the HARBOR trial presented at the Association for Research in Vision and Ophthalmology annual meeting.“What we wanted to show was that this stuff matters. It’s not just the beginning and the end, and at the end just because your OCT image is better and ultimately the patient is doing better,”… Read more »
  • STAAR’s EVO Viva receives CE mark
    European authorities granted STAAR Surgical approval to begin distributing the EVO+ Visian ICL with aspheric optic, according to a press release.The device is being marketed as EVO Viva and will first be available through select doctors in Spain, Germany and Belgium. In the coming months, the implant will be available more widely in Europe and other markets that recognize the CE mark, the release said.The ability of the lens to correct myopia and presbyopia was… Read more »
  • SightGlass targets global myopia progression with new spectacles
    Executives from SightGlass Vision, developers of novel spectacles designed to slow myopia progression in children, are hoping this treatment option can help address the increasing prevalence of this condition worldwide.Primary Care Optometry News spoke with SightGlass Vision chief medical officer Joe Rappon, OD, MS, FAAO, and founder and CEO Thomas W. Chalberg, PhD, about recent data on myopia progression and the CYPRESS trial outcomes for the company’s DOT Lenses for managing myopia.Rappon said that research… Read more »
  • The ‘Strange Fruit’ that haunts my days and dreams as a Black physician
    Billie Holiday recorded “Strange Fruit” in 1937.“Southern trees bear a strange fruit Blood on the leaves and blood at the root Black bodies swinging in the southern breeze Strange fruit hanging from the poplar trees”It is a beautifully sung protest of a deeply inhumane American legacy of racism — lynching. Imagine, only in 2020, the House passed The Emmett Till Antilynching Act, making lynching a federal crime. Having this anti-lynching bill stonewalled by the Senate… Read more »
  • NuEyes, ThirdEye launch augmented reality glasses
    NuEyes has partnered with ThirdEye to introduce the Pro 2 lightweight X2 MR Glasses for patients who have experienced visual impairment uncorrectable by traditional methods.“We’re excited to be partnering with NuEyes to help users read, watch television and movies, see faces and, ultimately, improve their quality of life,” Nick Cherukuri, founder and CEO of ThirdEye, said in a press release. “By combining our product with NuEyes’ patented software, the Pro 2 will improve day-to-day functions… Read more »
  • Petition, medical societies urge nationwide mask mandate
    More than 4,000 people have signed an online petition urging members of Congress to implement a national mandate that requires all Americans to wear masks or face coverings in public to stop the spread of COVID-19.The petition, which is still accepting signatures, was started by Illinois Medical Professionals Action Collaborative Team, or IMPACT, an organization co-founded by Shikha Jain MD, FACP. Jain is also host of Healio’s online podcast Oncology Overdrive.“A national mandate for universal… Read more »
  • Apellis completes phase 3 study enrollment of geographic atrophy treatment
    Enrollment is complete for two pivotal phase 3 studies of intravitreal pegcetacoplan, a targeted C3 therapy, for the treatment of geographic atrophy secondary to age-related macular degeneration.The DERBY and OAKS studies will include 1,259 patients. The randomized studies will evaluate the efficacy and safety of intravitreal pegcetacoplan (APL-2) compared with sham treatment, according to a press release from Apellis Pharmaceuticals.The primary outcome for each study will be the reduction in growth of geographic atrophy lesion… Read more »
  • Researchers: Myopia management may become standard of care
    Evidence-based research on the safety and efficacy of different treatments aided practitioners in managing myopia in children, according to a review published in Ophthalmic and Physiological Optics.“There may soon exist a continuum of care for myopia starting with delay of onset and followed by optical and pharmaceutical interventions to slow progression,” Kathryn Richdale, OD, PhD, of the University of Houston College of Optometry, and colleagues wrote. “It may be that spectacle prescriptions for myopic children… Read more »
  • VisionCare appoints new CEO
    Thomas Ruggia has been named as CEO of VisionCare, according to a press release.Ruggia is replacing Wolfgang Tolle, who also served as executive chairman of the board.Previously, Ruggia worked at Johnson & Johnson for 5 years, most recently as vice president WW customer experience and ocular surface disease at Johnson & Johnson Vision.“The opportunity to lead and grow VisionCare to serve a broader patient candidate pool is one that I embrace. I look forward to… Read more »
  • Researchers look to radiotherapy to treat severe cases of COVID-19
    Several trials exploring radiation’s potential as a treatment for critically ill patients with COVID-19 are underway in the United States.“COVID-19 patients often demonstrate a cytokine storm secondary to overactivation of the body’s own immune system,” Arnab Chakravarti, MD, chair of radiation oncology at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, told Healio Primary Care. “Administering ultra-low-dose radiation through high-energy X-ray beams may tamp… Read more »
  • Combined 5-FU/triamcinolone reduces chalazion size
    A single injection of 5-fluorouracil mixed with triamcinolone acetonide significantly reduced chalazia lesion size, improved appearance and reduced potential side effects compared with more invasive techniques, according to a study.“The success rates of this treatment were comparable with steroid injection alone,” Joshua M. Moran, BA, said at the virtual Association for Research in Vision and Ophthalmology meeting.Moran and colleagues evaluated chalazia treated with injections of a 9:1 mixture of 5-fluoruracil 50 mg/mL (Adrucil, Teva Pharmaceuticals)… Read more »
Was this information helpful?

Comments are closed.